Federal award
JADE THERAPEUTICS, INC.
W81XWH14C0025
ContractSBIR/STTR SR1
Obligated and Ceiling
- Obligated (net)
- $1,149,816.96
- Ceiling (potential value, not spending)
- $1,149,816.96
- Current value
- $1,149,816.96
- Gross positive obligations
- $1,149,817.70
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- JADE THERAPEUTICS, INC. · E7UNWJ3ES1Y5
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- EYEGATE PHARMACEUTICALS, INC. · LKWQP2FNVR44
- Awarding agency
- Department of War · sub-agency 2100 · office W81XWH
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- AN91 · R&D- MEDICAL: OTHER (BASIC RESEARCH)
- Industry (NAICS)
- 541712 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
- PIID
- W81XWH14C0025
- Award type code
- D
- Actions
- 6 · Jan 23, 2014 to Feb 18, 2021
- Why it is listed
- gross positive obligations of $100k or more (contracts); SBIR/STTR award
Action History6
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Feb 18, 2021 | FY2021 | P00005 | C | −$0.74 | — |
| Oct 11, 2017 | FY2018 | P00004 | M | $0.00 | — |
| Sep 21, 2016 | FY2016 | P00003 | C | $448,182.84 | — |
| Aug 14, 2015 | FY2015 | P00002 | C | $551,813.86 | — |
| Apr 2, 2015 | FY2015 | P00001 | G | $49,824.22 | — |
| Jan 23, 2014 | FY2014 | 0 | — | $99,996.78 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.